CalciMedica, Inc.CALCNASDAQ
Loading
R&D Expenses Over TimeStable
Percentile Rank29
3Y CAGR+22.2%
5Y CAGR-6.2%
Studio
Year-over-Year Change

Research and development spending

3Y CAGR
+22.2%/yr
vs -22.4%/yr prior
5Y CAGR
-6.2%/yr
Recent acceleration
Acceleration
+44.5pp
Accelerating
Percentile
P29
Within normal range
vs 5Y Ago
0.7x
Contraction
Streak
1 yr
Consecutive growthStable
PeriodValueYoY Change
TTM$15.23M+5.2%
2024$14.48M-8.7%
2023$15.86M+89.9%
2022$8.35M-55.8%
2021$18.90M-9.8%
2020$20.96M-31.5%
2019$30.58M+33.1%
2018$22.97M-